Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Leukemia Research|January 1, 1986
Effects of ex-vivo plasma adsorption over protein A sepharose in acute leukemiaP Solal-Celigny, J Simeon, A Herrera, et al.
Gastroenterology|March 12, 2013
Consumption of fermented milk product with probiotic modulates brain activityKirsten Tillisch, Jennifer Labus, Lisa Kilpatrick, et al.
Frontiers in Microbiology|January 8, 2024
Comparing technology and regulatory landscape of probiotics as food, dietary supplements and live biotherapeuticsIrina Spacova, Sylvie Binda, Jessica Anne Ter Haar, et al.
Neurogastroenterology and Motility|January 26, 2012
A marketed fermented dairy product containing Bifidobacterium lactis CNCM I-2494 suppresses gut hypersensitivity and colonic barrier disruption induced by acute stress in ratsS Agostini, M Goubern, V Tondereau, et al.
Allergy|May 19, 2017
Lung function parameters in omalizumab responder patients: An interesting tool?F Paganin, G Mangiapan, A Proust, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 18, 2023
Lactococcus lactis CNCM I-5388 versus NCDO2118 by its GABA hyperproduction ability, counteracts faster stress-induced intestinal hypersensitivity in ratsPedro Gomes, Valérie Laroute, Catherine Beaufrand, et al.
Oncoimmunology|April 15, 2025
Final 3-year results from the EVIDENS study, an observational study of nivolumab in non-small cell lung cancerFabrice Barlesi, Adrien Dixmier, Didier Debieuvre, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 22, 2025
Postbiotic potential of Lactococcus lactis CNCM I-5388 in alleviating visceral pain in female rat through GABA production: The innovative concept of the "active-GAD bag"Pedro Gomes, Valérie Laroute, Catherine Beaufrand, et al.
Plos One|January 8, 2019
Clinical efficacy and cost-effectiveness of endobronchial ultrasound-guided transbronchial needle aspiration for preoperative staging of non-small-cell lung cancer: Results of a French prospective multicenter trial (EVIEPEB)Christos Chouaid, Mathieu Salaün, Valérie Gounant, et al.
Oncoimmunology|January 18, 2021
Effectiveness and safety of nivolumab in the treatment of lung cancer patients in France: preliminary results from the real-world EVIDENS studyFabrice Barlesi, Adrien Dixmier, Didier Debieuvre, et al.
Pageof 7